Menu

WHY US? BECAUSE EARLY DIAGNOSIS IS KEY

Currently, only about 15% of those diagnosed with pancreatic cancer are eligible for potentially curative surgery. We need to find the disease earlier!

Pancreatic cancer is very aggressive. Fortunately together, so are we.

We are dedicated to promoting awareness, increasing education, and furthering pancreatic cancer research.

INTERESTING ASSORTED TOPICS ON PANCREATIC CANCER

Pancreatic Cancer

Malignant cancer is a tumor (or growth) in which an aggregation of individual cells begins to grow in a rapid, uncontrolled and abnormal manner; and which may spread by aggressive local extension or by the seeding of other organs through blood vessel channels or via the lymphatic system. There also exist benign tumors which tend to be (but are not always) less serious, which tend to grow more slowly and orderly, and which tend not to spread by colonizing into other parts of the body (this process known as metastasis). Cancer can arise from virtually any kind of cell in the body.

In up to 95% of cases, pancreatic cancer arises from the exocrine portion of the organ. The least common exocrine pancreatic cancer comes from acinar cells. Most of the exocrine tumors (~90%) are from ductal cells–those which line the pancreatic ducts. These tumors are classified as carcinomas, a word that refers to tumors arising from a lining cell. Further, under the microscope, the appearance and arrangement of these carcinoma cells can appear as duct-like (or “adeno”) giving the term adenocarcinoma to this most common form of pancreatic cancer.

About three-quarters of exocrine pancreatic cancer arises in the head and neck of the pancreas (the anatomic parts through which the pancreatic duct runs just before it meets the duodenum). Some of these carcinomas arise in the body of the pancreatic organ, and less than ten percent arise in the tail of the pancreas (the tapering smaller “left” area, closest to the spleen).

Pancreatic cancer is one of the most aggressive cancers, one of the most non-responsive to treatment, and one of the hardest to diagnose.

Pancreatic cancer is the 4th leading cause of cancer death in the United States. It’s estimated that over 50,000 new cases are diagnosed each year and over 40,000 people die because of this disease annually.

The lifetime risk of developing the disease is 1.6%. The risk is about the same for men and women and the typical range of age at the time of diagnosis is between 65-74 years old.

Our science board is composed of:

James Abbruzzese, MD Chief, Medical Oncology Duke University

Markus Büchler, MD Chairman, Surgery Heidelberg University, Germany

Ralph Hruban, MD Director, GI / Liver Pathology Johns Hopkins University

Eileen O’Reilly, MD Associate Director for Clinical Research – Memorial Sloan-Kettering Cancer Center

Margaret Tempero, MD Chief, Medical Oncology University of California at San Francisco

Our Philosophy About Pancreatic Cancer

Pancreatic cancer is a serious disease. Taking an aggressive rational stance at the earliest possible time, supported by the best medical team, and treated in the most appropriate manner gives the best chance for survival.

We believe in strong patient-physician bonds, scientifically-based treatment, and that comfort can come from knowing that everything that reasonably can be done – is being done.

That the best approach is meeting cancer of the pancreas head-on and armed with the best available information.

Cancer Patients Alliance is a 501(c)(3) non-profit. Initiatives include, ToFightCancer.com and Pancreatica.org. All Donations are tax-deductible. Pancreatic cancer is the least funded cancer in terms of research.

Despite causing enormous mortality, pancreatic cancer receives (on a mortality basis) much less funding for research than most of the other major cancers. Currently, there is no molecular marker or genetic screening tool to aid in the earlier diagnosis or screening of pancreatic cancer. Treatment results would improve significantly if this cancer could be diagnosed at an earlier stage.

Amazon donates 0.5% of the price of your eligible AmazonSmile purchases to help fight pancreatic cancer!
AmazonSmile is the same Amazon you know. Same products, same prices, same service. Simply use our Link to start shopping!

All Donations are tax-deductible.

Walk, Run, or Choose your own!

Walk or Run any Fun Run, Color Run, 5K, 10K, Half Marathon or Full Marathon Race!

– Find local Events –
1. Active.com
2. RunningInTheUSA
3. Runners World

CREATE YOUR OWN FUNDRAISER using Peer to Peer!

 Peer to Peer is a fundraising method that helps you raise money by setting up a fundraising page and sharing with friends and family!

 

FUNDRAISING ON FACEBOOK​ IS SO EASY!

Dedicate your birthday to fight pancreatic cancer or simply set up a page to honor a loved one.

Our mission is to promote awareness, increase education, and further pancreatic cancer research, specifically research aimed at early diagnosis.

Early diagnosis is key:
Survival increases dramatically if patients are diagnosed in time for surgery!

© 2019 Pancreatica. All rights reserved | Privacy Policy 312 Fountain Avenue, Pacific Grove, California 93950   |   Phone: (831) 658-0600   |   Fax: (831) 658-0518  |  participate@tofightcancer.com

Dedicate your birthday to fight pancreatic cancer or simply set up a page to honor a loved one.